|
Jun 26
|
Revealing Undervalued Asian Stocks Including Simcere Pharmaceutical Group And Two Others
|
|
Jun 19
|
Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Patients with Relapsed/Refractory Multiple Myeloma
|
|
Jun 16
|
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
|